The Canadian Institutes of Health Research will lead a landmark research competition to develop personalized treatments for various diseases, including cancer, cardiovascular disease, and neurodegenerative disorders. The investment aims to transform the delivery of healthcare through predictive, preventive, and precision care.
The Canadian Institutes of Health Research has funded 25 policy-relevant research projects across six provinces to strengthen Canada's healthcare system. These projects will enable meaningful collaborations between researchers and decision makers to address health system challenges.
The Canadian Institutes of Health Research has awarded $16 million in funding for seven new research projects on regenerative medicine and nanomedicine. These studies aim to develop new therapies and approaches to treat illnesses and diseases, ultimately improving patient outcomes.
The Canadian government and Heart and Stroke Foundation have launched three new research initiatives to tackle obesity, focusing on neighbourhood design, physical activity, and access to healthy food options.
Grand Challenges Canada and Canadian partners have joined forces to tackle Neglected Tropical Diseases (NTDs) affecting over 1 billion people worldwide. Researchers will develop new drugs using compounds from African botanical and microbial sources, collaborating with African scientists.
The Government of Canada is supporting scientific research to deepen knowledge of the H1N1 flu virus. Five new projects, totaling $2.4 million over two years, will investigate how to manage health-care resources during a pandemic, impact on pregnant women, and development of new drug therapies.
Health professionals face challenges in addressing Indigenous health disparities due to colonization and globalization, according to Canadian researchers. Traditional healing practices, language retention, and self-determination are key factors in promoting well-being for Indigenous peoples.
The Canadian Institutes of Health Research and Natural Sciences and Engineering Research Council are partnering to fund $6 million in research for alternative, non-nuclear medical isotopes. The goal is to address the medical isotope shortage and support the production and clinical testing of these alternatives.
A new parent questionnaire, Language Use Inventory (LUI), has been developed to evaluate language skills in children with autism. The LUI assesses pragmatic language development, which is critical for effective communication in everyday interactions.
The Government of Canada has funded a national influenza research network to evaluate the safety and effectiveness of pandemic influenza vaccines. The network, led by Dr. Scott Halperin, will provide a pan-Canadian coordinating mechanism for conducting applied public health research on the H1N1 flu virus.
The Canadian Institutes of Health Research is launching a large-scale study to understand common health problems affecting seniors. The two-decade long study will follow 50,000 Canadians and explore biological, medical, psychological, social, and economic factors that impact their health over time.
The Canadian Institutes of Health Research (CIHR) is providing $4.4 million in funding to support three research teams investigating ways to improve the application of mental health research in Canada.
A team of researchers led by University of Saskatchewan microbiologist Wei Xiao has found a way to trigger a protein combination that sends an SOS signal for cells to fight cancer-causing agents. The discovery could lead to better cancer diagnosis and potentially pave the way for a new type of drug.
The Canadian Institutes of Health Research (CIHR) has announced over $298 million in funding for 764 health research projects across Canada. The funded research will focus on addressing important health issues like cancer, heart disease, and HIV/AIDS.
Researchers discovered a novel gut-brain-liver circuit that lowers blood sugar when activated, providing a potential new approach to treat diabetes. The discovery suggests stimulating the gut's sensing mechanism may slow down sugar production and lower blood sugar levels.
Dr. Richard Stein has been awarded the Barbara Turnbull Award for Spinal Cord Research, a $50,000 prize, for his work on direct, microelectrical spinal cord stimulation. His innovative device aims to record sensory feedback from muscles and nerves in legs and hips to help paralyzed individuals walk.
Researchers at the University of Saskatchewan have isolated a plant gene that helps plants resist environmental stresses. The study's findings could lead to the development of crops with improved tolerance to ultra-violet light and other types of radiation, ultimately benefiting agricultural productivity and ecosystem health.
Researchers have discovered a weakness in the armour that protects B. cenocepacia from antibiotics, identifying a key sugar required for its protection. This finding may lead to novel molecules to disrupt its synthesis and develop new treatments.
A CIHR-funded study found that while antidepressants reduce alcohol consumption in men with depression, this effect is lost for women. Men taking antidepressants consumed significantly less alcohol than depressed men who did not use antidepressants.
A randomized controlled trial conducted in Kenya demonstrates that male circumcision significantly reduces the risk of acquiring HIV, with a 53% reduction in new infections among circumcised men. The study, funded by CIHR, provides conclusive evidence supporting the use of circumcision as an important HIV prevention strategy.
Dr. Pierre Drapeau's research on zebrafish embryos has led to the discovery of signaling between nerve cells' importance in spinal cord development and growth. The $50,000 Barbara Turnbull Award supports his work towards understanding spinal cord repair and potentially treating diseases such as schizophrenia and autism.
Dr. Pierre Drapeau is being awarded the highest distinction in Canadian spinal cord research for his pioneering study of spinal cord development using the zebrafish embryo. This groundbreaking work has opened new avenues for understanding vertebrate development and genetics.
A study conducted by Dr. Benedikt Fischer and his team reveals that prescription opioids are the major form of illicit opioid use in seven Canadian cities, surpassing heroin use. The findings suggest a significant decline in heroin use among participants between 2001 and 2005.
The U.S. Vaccine and Infectious Disease Organization has discovered a crucial pathway that supports the influenza A virus's ability to reproduce itself. This finding could lead to the development of new live vaccines and antiviral drugs for influenza epidemics and pandemics.
A Canadian study found that medical induction of labor increases the risk of amniotic-fluid embolism, a rare but serious complication. The study examined three million hospital births in Canada and found a significant association between AFE and medical induction.
The CANADA-HOPE Scholarship Program aims to improve the health of people in developing countries through research. The three recipients will study healthy aging, organ damage and stroke research in Canada before returning to their home institutions to establish productive research programs.
A team of Canadian and American researchers has identified the role of SHP-1 in regulating blood glucose levels and insulin sensitivity. The study used genetically modified mice to demonstrate that SHP-1 inhibition can improve glucose metabolism at the liver and muscle levels, potentially leading to new treatments for type 2 diabetes.
Health researchers across Canada will investigate social determinants of health, ethnic influences on aging, and disparities among Aboriginal peoples, children, rural youth, seniors, and sexual minorities. The research aims to improve the lives of vulnerable Canadians and build stronger communities.
The Canadian Institutes of Health Research has invested $900,000 over five years to fund the first Canadian Chair in Hypertension Prevention and Control. Dr. Norm Campbell will lead a multi-faceted approach to primary prevention and treatment of hypertension.
A $4.5 million partnership aims to improve lung health by studying immune responses to infections and allergens in Canadians affected by asthma, cystic fibrosis, and other respiratory diseases. Experts available for comment on the initiative and its implications.
A new study will develop a cohort of 1,000 HIV-infected IDUs with a history of injection drug use to examine treatment access and adherence. The research aims to improve access to life-saving HIV and HCV treatments for marginalized individuals in Vancouver's Downtown Eastside.
A $1.2 million investment from FRSQ and its partners will support research on C. difficile in Quebec, aiming to improve diagnosis and treatment of the condition. The project involves a multidisciplinary approach, combining epidemiology, clinical factors, microbial genetics, and more.
A new study by Dr. Greg Steinberg reveals that CNTF activates skeletal muscle AMP kinase, increasing fat metabolism and reducing the risk of metabolic abnormalities associated with excess weight. This finding opens the door to new strategies for obesity treatment.
Dr. Joseph Culotti's research into nerve cell growth and migration may lead to future spinal cord repair processes. He was awarded the $50,000 Barbara Turnbull Prize in recognition of his contributions to world-leading spinal cord research in Canada.
Researchers at McGill University have developed advanced MRI methods to improve detection of brain lesions in epilepsy patients. These new techniques reduce complexity and cost of pre-surgical evaluation, paving the way for more surgical treatment options.
Researchers at Canadian Institutes of Health Research find that bone marrow-derived microglia can efficiently destroy amyloid plaques, the hallmark of Alzheimer's disease. The discovery provides new hope for patients by highlighting a potential therapeutic approach to curbing plaque development and prolonging autonomy.
A team of researchers, led by Xia Zhang, has discovered a potential universal strategy for treating drug addiction. They found that a naturally occurring enzyme called PTEN acts on the ventral tegmental area (VTA) of the brain, where many drugs of abuse exert their rewarding effects.
Researchers have identified a key gene associated with rare but important pregnancy disorders, including molar pregnancies, spontaneous abortions, and stillbirths. The discovery has significant implications for developing new treatments and therapies for these conditions.
U.S. researchers have developed a new vaccine candidate against hepatitis C using dendritic cells, which reduced the amount of carrier virus expressing HCV protein in mice by 100,000 times compared to controls. The study's findings offer a promising approach to prevent liver disease and eliminate the virus from the body.
The Canadian Institutes of Health Research (CIHR) has released research reports on wait times for cancer, joint replacement, and sight restoration. The studies provide a framework for developing evidence-based benchmarks and identifying gaps in existing research.
The new J. David Grimes Research Chair at the University of Ottawa will explore brain cell function to advance understanding and treatment of neurological disorders such as Parkinson's disease, epilepsy, schizophrenia, and depression. The chair is named after Dr. J. David Grimes, founder of the Loeb Research Institute, who made signifi...
The Government of Canada has invested $2.8 million to fund 13 health research projects on childhood obesity, which affects 26% of Canadian children aged 2-17. The projects will focus on creating healthy, active schools and developing programs to tackle the issue.
A Canadian Institutes of Health Research-funded study found that full-term breech presentation is safest with a planned caesarian section. Babies in the caesarian group were 3-4 times less likely to die or have serious problems within six weeks, especially in developed countries.